- Main
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.
- Hassan, Manal;
- Li, Donghui;
- Han, Younghun;
- Byun, Jinyoung;
- Hatia, Rikita;
- Long, Erping;
- Choi, Jiyeon;
- Kelley, Robin;
- Cleary, Sean;
- Lok, Anna;
- Bracci, Paige;
- Permuth, Jennifer;
- Bucur, Roxana;
- Yuan, Jian-Min;
- Singal, Amit;
- Jalal, Prasun;
- Ghobrial, R;
- Santella, Regina;
- Kono, Yuko;
- Shah, Dimpy;
- Nguyen, Mindie;
- Liu, Geoffrey;
- Parikh, Neehar;
- Kim, Richard;
- Wu, Hui-Chen;
- El-Serag, Hashem;
- Chang, Ping;
- Li, Yanan;
- Chun, Yun;
- Lee, Sunyoung;
- Gu, Jian;
- Hawk, Ernest;
- Sun, Ryan;
- Huff, Chad;
- Rashid, Asif;
- Amin, Hesham;
- Beretta, Laura;
- Wolff, Robert;
- Antwi, Samuel;
- Patt, Yehuda;
- Hwang, Lu-Yu;
- Klein, Alison;
- Zhang, Karen;
- Schmidt, Mikayla;
- White, Donna;
- Goss, John;
- Khaderi, Saira;
- Marrero, Jorge;
- Cigarroa, Francisco;
- Shah, Pankil;
- Kaseb, Ahmed;
- Roberts, Lewis;
- Amos, Christopher
- et al.
Published Web Location
https://doi.org/10.1097/HEP.0000000000000800Abstract
BACKGROUND AND AIMS: Despite the substantial impact of environmental factors, individuals with a family history of liver cancer have an increased risk for HCC. However, genetic factors have not been studied systematically by genome-wide approaches in large numbers of individuals from European descent populations (EDP). APPROACH AND RESULTS: We conducted a 2-stage genome-wide association study (GWAS) on HCC not affected by HBV infections. A total of 1872 HCC cases and 2907 controls were included in the discovery stage, and 1200 HCC cases and 1832 controls in the validation. We analyzed the discovery and validation samples separately and then conducted a meta-analysis. All analyses were conducted in the presence and absence of HCV. The liability-scale heritability was 24.4% for overall HCC. Five regions with significant ORs (95% CI) were identified for nonviral HCC: 3p22.1, MOBP , rs9842969, (0.51, [0.40-0.65]); 5p15.33, TERT , rs2242652, (0.70, (0.62-0.79]); 19q13.11, TM6SF2 , rs58542926, (1.49, [1.29-1.72]); 19p13.11 MAU2 , rs58489806, (1.53, (1.33-1.75]); and 22q13.31, PNPLA3 , rs738409, (1.66, [1.51-1.83]). One region was identified for HCV-induced HCC: 6p21.31, human leukocyte antigen DQ beta 1, rs9275224, (0.79, [0.74-0.84]). A combination of homozygous variants of PNPLA3 and TERT showing a 6.5-fold higher risk for nonviral-related HCC compared to individuals lacking these genotypes. This observation suggests that gene-gene interactions may identify individuals at elevated risk for developing HCC. CONCLUSIONS: Our GWAS highlights novel genetic susceptibility of nonviral HCC among European descent populations from North America with substantial heritability. Selected genetic influences were observed for HCV-positive HCC. Our findings indicate the importance of genetic susceptibility to HCC development.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
Enter the password to open this PDF file:
-
-
-
-
-
-
-
-
-
-
-
-
-
-